The global demand for Glaucoma Market is presumed to reach the market size of nearly USD 13.64 BN by 2030 from USD 9.09 BN in 2022 with a CAGR of 5.21% under the study period 2023 - 2030.
Glaucoma refers to an eye condition that affects the optic nerve, which is capable of transmitting visual signals from the eye to the brain. This condition is often associated with elevated intraocular pressure (pressure within the eye), but it can also occur with normal or even low eye pressure.
The increasing prevalence of glaucoma due to the ageing global population has pushed the demand for effective diagnostic and treatment options. Its growing awareness and the significance of early detection have resulted in more individuals seeking screenings and treatment. Technological advancements in diagnostic tools, such as optical coherence tomography and visual field testing, have enhanced early detection accuracy. Innovations in glaucoma treatment, including new eye drops, minimally invasive surgeries, and sustained-release drug delivery systems, have expanded treatment options. Rising healthcare expenditure and favourable reimbursement policies have encouraged investments in diagnostics and treatments. Collaborations between pharmaceutical companies, medical device manufacturers, and research institutions have facilitated advancements in glaucoma therapies. Government initiatives and public health campaigns promoting eye health have contributed to increased patient visits to eye care professionals. The growing geriatric population, advancements in drug delivery systems, and a focus on vision health have further fueled the market's expansion. As glaucoma prevalence continues to rise and awareness about early detection grows, manufacturers and healthcare organizations are expected to invest in product development, marketing strategies, and patient education to meet the evolving needs of patients and eye care professionals.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of glaucoma. The growth and trends of glaucoma industry provide a holistic approach to this study.
This section of the glaucoma market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Disease Type
By Drug Class
By Distribution Channel
This section covers the regional outlook, which accentuates current and future demand for the Glaucoma market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Glaucoma market include Pfizer Inc., Santen Pharmaceutical Co., Ltd., Novartis AG, Alcon Inc., Akron Operating Company LLC, Thea Pharma, AbbVie, Inc., Bausch + Lomb Corporation, Teva Pharmaceuticals Industries Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . GLAUCOMA – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Disease Type
3.7.2 Market Attractiveness Analysis By Drug Class
3.7.3 Market Attractiveness Analysis By Distribution Channel
3.7.4 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . GLOBAL GLAUCOMA MARKET ANALYSIS BY DISEASE TYPE
5.1 Overview by Disease Type
5.2 Historical and Forecast Data
5.3 Analysis by Disease Type
5.4 Open Angle Glaucoma Historic and Forecast Sales by Regions
5.5 Angle Closure Glaucoma Historic and Forecast Sales by Regions
5.6 Others Historic and Forecast Sales by Regions
6 . GLOBAL GLAUCOMA MARKET ANALYSIS BY DRUG CLASS
6.1 Overview by Drug Class
6.2 Historical and Forecast Data
6.3 Analysis by Drug Class
6.4 Prostaglandins Analogs Historic and Forecast Sales by Regions
6.5 Beta-blockers Historic and Forecast Sales by Regions
...